Pathogenesis of high altitude pulmonary edema: Does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak?

Robert J. Kaner, Ronald Crystal

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is a potent mediator of capillary leak if it gains access to its receptors on the capillary endothelium. We have observed that there are high levels of VEGF compartmentalized in the alveolar epithelial lining fluid of normal humans at levels 500-fold greater than plasma. The potential for high altitude to result in compromise of alveolar epithelial tight junctions and experimental animal studies in which pulmonary edema is induced when VEGF is overexpressed in the alveolar epithelium, suggest a mechanism. We hypothesize that when the epithelial barrier is compromised at high altitude the normally high level of VEGF in the alveolar epithelial fluid has access to the pulmonary endothelium, where it acutely alters permeability, markedly exacerbating the high permeability pulmonary edema that characterizes high altitude pulmonary edema. If correct, this paradigm opens the possibility of testing available anti-VEGF therapies to treat this potentially fatal disorder.

Original languageEnglish
Pages (from-to)399-409
Number of pages11
JournalHigh Altitude Medicine and Biology
Volume5
Issue number4
DOIs
Publication statusPublished - 1 Dec 2004
Externally publishedYes

Fingerprint

Pulmonary Edema
Vascular Endothelial Growth Factor A
Permeability
Tight Junctions
Vascular Endothelium
Endothelium
Epithelium
Lung

Keywords

  • Animal models
  • Blood-gas barrier or barrier function
  • Bronchoalveolar lavage
  • Lung
  • Molecular pathophysiology
  • Permeability

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Public Health, Environmental and Occupational Health

Cite this

@article{c2d634a7f42142dc8e2cebff6794da5c,
title = "Pathogenesis of high altitude pulmonary edema: Does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak?",
abstract = "Vascular endothelial growth factor (VEGF) is a potent mediator of capillary leak if it gains access to its receptors on the capillary endothelium. We have observed that there are high levels of VEGF compartmentalized in the alveolar epithelial lining fluid of normal humans at levels 500-fold greater than plasma. The potential for high altitude to result in compromise of alveolar epithelial tight junctions and experimental animal studies in which pulmonary edema is induced when VEGF is overexpressed in the alveolar epithelium, suggest a mechanism. We hypothesize that when the epithelial barrier is compromised at high altitude the normally high level of VEGF in the alveolar epithelial fluid has access to the pulmonary endothelium, where it acutely alters permeability, markedly exacerbating the high permeability pulmonary edema that characterizes high altitude pulmonary edema. If correct, this paradigm opens the possibility of testing available anti-VEGF therapies to treat this potentially fatal disorder.",
keywords = "Animal models, Blood-gas barrier or barrier function, Bronchoalveolar lavage, Lung, Molecular pathophysiology, Permeability",
author = "Kaner, {Robert J.} and Ronald Crystal",
year = "2004",
month = "12",
day = "1",
doi = "10.1089/ham.2004.5.399",
language = "English",
volume = "5",
pages = "399--409",
journal = "High Altitude Medicine and Biology",
issn = "1527-0297",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Pathogenesis of high altitude pulmonary edema

T2 - Does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak?

AU - Kaner, Robert J.

AU - Crystal, Ronald

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Vascular endothelial growth factor (VEGF) is a potent mediator of capillary leak if it gains access to its receptors on the capillary endothelium. We have observed that there are high levels of VEGF compartmentalized in the alveolar epithelial lining fluid of normal humans at levels 500-fold greater than plasma. The potential for high altitude to result in compromise of alveolar epithelial tight junctions and experimental animal studies in which pulmonary edema is induced when VEGF is overexpressed in the alveolar epithelium, suggest a mechanism. We hypothesize that when the epithelial barrier is compromised at high altitude the normally high level of VEGF in the alveolar epithelial fluid has access to the pulmonary endothelium, where it acutely alters permeability, markedly exacerbating the high permeability pulmonary edema that characterizes high altitude pulmonary edema. If correct, this paradigm opens the possibility of testing available anti-VEGF therapies to treat this potentially fatal disorder.

AB - Vascular endothelial growth factor (VEGF) is a potent mediator of capillary leak if it gains access to its receptors on the capillary endothelium. We have observed that there are high levels of VEGF compartmentalized in the alveolar epithelial lining fluid of normal humans at levels 500-fold greater than plasma. The potential for high altitude to result in compromise of alveolar epithelial tight junctions and experimental animal studies in which pulmonary edema is induced when VEGF is overexpressed in the alveolar epithelium, suggest a mechanism. We hypothesize that when the epithelial barrier is compromised at high altitude the normally high level of VEGF in the alveolar epithelial fluid has access to the pulmonary endothelium, where it acutely alters permeability, markedly exacerbating the high permeability pulmonary edema that characterizes high altitude pulmonary edema. If correct, this paradigm opens the possibility of testing available anti-VEGF therapies to treat this potentially fatal disorder.

KW - Animal models

KW - Blood-gas barrier or barrier function

KW - Bronchoalveolar lavage

KW - Lung

KW - Molecular pathophysiology

KW - Permeability

UR - http://www.scopus.com/inward/record.url?scp=14644415579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644415579&partnerID=8YFLogxK

U2 - 10.1089/ham.2004.5.399

DO - 10.1089/ham.2004.5.399

M3 - Article

C2 - 15671629

AN - SCOPUS:14644415579

VL - 5

SP - 399

EP - 409

JO - High Altitude Medicine and Biology

JF - High Altitude Medicine and Biology

SN - 1527-0297

IS - 4

ER -